Ebselen and Naproxen induced apoptosis and mda-7/IL-24 expression in ovarian cancer cells and also synergized with the more potent NSAIDs, Diclofenac and Sulindac Sulfide, suggesting potential clinical utility in ovarian cancer therapy. This evidence concerns the gene IL24 and ovarian cancer.